Korean Journal of Radiology

The Korean Society of Radiology (대한영상의학회)
권호 표지
DOI QR코드

DOI QR Code

An Incidentally Found Inflamed Uterine Myoma Causing Low Abdominal Pain, Using Tc-99m-Tektrotyd Single Photon Emission Computed Tomography-CT Hybrid Imaging

  • Zandieh, Shahin (Institute of Radiology and Nuclear Medicine, Hanusch-Hospital, Teaching Hospital of Medical University of Vienna) ;
  • Schutz, Matthias (Institute of Radiology and Nuclear Medicine, Hanusch-Hospital, Teaching Hospital of Medical University of Vienna) ;
  • Bernt, Reinhard (Institute of Radiology and Nuclear Medicine, Hanusch-Hospital, Teaching Hospital of Medical University of Vienna) ;
  • Zwerina, Jochen (Ludwig Boltzmann Institute of Osteology at the 1st Medical Department and AUVA Trauma Center Meidling, Hanusch-Hospital, Teaching Hospital of Medical University of Vienna) ;
  • Haller, Joerg (Institute of Radiology and Nuclear Medicine, Hanusch-Hospital, Teaching Hospital of Medical University of Vienna)
  • Received : 2012.11.03
  • Accepted : 2013.04.15
  • Published : 2013.09.01
⟨ Previous Next ⟩

Abstract

We report the case of a 50-year-old woman presented with a history of right hemicolectomy due to an ileocecal neuroendocrine tumor and left breast metastasis. Owing to a slightly elevated chromogranin A-level and lower abdominal pain, single photon emission computed tomography-computer tomography (SPECT-CT) was performed. There were no signs of recurrence on the SPECT-CT scan, but the patient was incidentally found to have an inflamed intramural myoma. We believe that the slightly elevated chromogranin A-level was caused by the hypertension that the patient presented. In the clinical context, this is a report of an inflamed uterine myoma seen as a false positive result detected by TC-99m-Tc-EDDA/HYNIC-Tyr3-Octreotide (Tektrotyd) SPECT-CT hybrid imaging.

Keywords

References

  1. Kolby L, Wängberg B, Ahlman H, Tisell LE, Fjälling M, Forssell- Aronsson E, et al. Somatostatin receptor subtypes, octreotide scintigraphy, and clinical response to octreotide treatment in patients with neuroendocrine tumors. World J Surg 1998;22:679-683 https://doi.org/10.1007/s002689900452
  2. Krenning EP, Kwekkeboom DJ, Bakker WH, Breeman WA, Kooij PP, Oei HY, et al. Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993;20:716-731 https://doi.org/10.1007/BF00181765
  3. Eubank WB, Mankoff DA, Schmiedl UP, Winter TC 3rd, Fisher ER, Olshen AB, et al. Imaging of oncologic patients: benefit of combined CT and FDG PET in the diagnosis of malignancy. AJR Am J Roentgenol 1998;171:1103-1110 https://doi.org/10.2214/ajr.171.4.9763005
  4. Walsh JW. Computed tomography of gynecologic neoplasms. Radiol Clin North Am 1992;30:817-830
  5. Kwekkeboom D, Krenning EP, de Jong M. Peptide receptor imaging and therapy. J Nucl Med 2000;41:1704-1713
  6. Joseph K, Stapp J, Reinecke J, Skamel HJ, Höffken H, Neuhaus C, et al. Receptor scintigraphy with 111Inpentetreotide for endocrine gastroenteropancreatic tumors. Horm Metab Res Suppl 1993;27:28-35
  7. Gibril F, Reynolds JC, Chen CC, Yu F, Goebel SU, Serrano J, et al. Specificity of somatostatin receptor scintigraphy: a prospective study and effects of false-positive localizations on management in patients with gastrinomas. J Nucl Med 1999;40:539-553
  8. Vanhagen PM, Krenning EP, Reubi JC, Kwekkeboom DJ, Bakker WH, Mulder AH, et al. Somatostatin analogue scintigraphy in granulomatous diseases. Eur J Nucl Med 1994;21:497-502
  9. Mena LM, Martin F, Jimenez I, Ramos A. In-111 pentetreotide uptake in a uterine myoma. Clin Nucl Med 2010;35:524-525 https://doi.org/10.1097/RLU.0b013e3181e06021
  10. O'Connor DT. Plasma chromogranin A. Initial studies in human hypertension. Hypertension 1985;7(3 Pt 2):I76-I79 https://doi.org/10.1161/01.HYP.7.3_Pt_2.I76

Cited by

  1. Incidentally Detected High SSTR Expression in Uterine Leiomyoma on DOTANOC PET/CT vol.47, pp.1, 2022, https://doi.org/10.1097/rlu.0000000000003850